RECRUITINGOBSERVATIONAL
Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
About This Trial
To date, there are no reliable diagnostic blood markers of adult vasculitis. To date, the diagnosis of vasculitis is based on invasive procedure, biopsy of affected tissues potentially at risk of complication . In addition, there are no reliable biomarkers to predict the evolution of vasculitis (relapse, refractory form ...) necessary for the management of patients (type of treatment, duration ..) Prospective study, monocentric (CHU de Tours), non-interventional, aimed at finding diagnostic and prognostic biomarkers (both metabolomic and immunologic) in adult vasculitis patients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age \> 16 years
- Active vasculitis, new diagnosis or relapse
- IgA vasculitis
- ANCA vasculitis
- Giant cell arteritis
Who Should NOT Join This Trial:
- Person who has objected to the processing of data
- Pregnant woman
- Patient positive for HIV, HBV, HCV
- Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.
- Patient unable to understand the information leaflet
- Adult under guardianship or curatorship
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age \> 16 years
* Active vasculitis, new diagnosis or relapse
* IgA vasculitis
* ANCA vasculitis
* Giant cell arteritis
Exclusion Criteria:
* Person who has objected to the processing of data
* Pregnant woman
* Patient positive for HIV, HBV, HCV
* Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.
* Patient unable to understand the information leaflet
* Adult under guardianship or curatorship
Treatments Being Tested
OTHER
Sampling
4 blood sampling per patient and an additional one in case of relapse
Locations (1)
University hospital
Tours, France